NEUMEDICINES, INC.
Biotech · Private
Recombinant human interleukin-12 (rHuIL-12) therapeutic for cutaneous T-cell lymphoma
- Grants
- $1.5M
- 2 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 34
- 3 granted · 31 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201420152016
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · A Phase IIa Study of rHuIL-12 as an Immunotherapy and Radiomitigator for CTCL Patients Receiving Radiotherapy | $1,088,333 | |
| Federal grant | Department of Health and Human Services · Phase II · A Phase IIa Study of rHuIL-12 as an Immunotherapy and Radiomitigator for CTCL Patients Receiving Radiotherapy | $417,175 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1418 | Omm Scientific, Inc | — | — |
| 1419 | EVODENOVO INC | — | — |
| 1420 | Link Biosystems Inc. | — | — |
| 1421 | NEUMEDICINES, INC. | — | — |
| 1422 | Rectify Pharmaceuticals LLC | — | — |
| 1423 | MOLECULAR THERANOSTICS, LLC | — | — |
| 1424 | Prime Medicine | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Use Of IL-12 To Generate Endogenous Erythropoietinapplication
- IL-12 Compositions And Methods Of Use In Hematopoietic Recoveryapplication
- IL-12 Formulations For Enhancing Hematopoiesisapplication
- Methods For Radiation Protection By Administering IL-12granted
- IL-12 For Radiation Protection And Radiation-induced Toxicity Mitigationgranted
- Method For Treating Brain Cancer Using A Novel Tumor Suppressor Gene And Secreted Factorgranted
- Uses Of IL-12 In Hematopoietic Immunotherapy (hit)application
- IL-12 Compositions And Methods Of Use In Hematopoietic Recoveryapplication
- Endogenous Vaccine For Cancer And Infectious Diseasesapplication
- Methods For Treating Cancer Using Compositions Comprising HSS1 And/or HSM1application
- Use Of IL-12 To Increase Survivalapplication
- Uses Of IL-12 And The IL-12 Receptor Positive Cell In Tissue Repair And Regenerationapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.